MedTrace Logo

Can Vitamin D3 Supplementation Affect Treatment Outcomes in Patients With Depression

NCT01390662 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2012-03-28

No results posted yet for this study

Summary

The purpose of this study is to investigate whether patients with depression should be offered vitamin D supplements, or it has no significance in relation to treatment outcomes.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

one tablet of vitamin D3 70 µg pr. day, for 24 weeks.

DIETARY_SUPPLEMENT

placebo

one tablet of sugar pill pr. day, for 24 weeks.

Sponsors & Collaborators

  • Region Syddanmark

    lead OTHER

Principal Investigators

  • Connie T Nielsen, PhD · Mental Health Services Esbjerg

  • Erik Dahl, MD · Mental Health Services Svendborg

  • Tomas toft, PhD · Mental Health Services Odense

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2012-05-31
Completion
2012-12-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01390662 on ClinicalTrials.gov